Insight
Matt Sagan

Matt Sagan: Innovative approach of HER2 expression quantitative assessment using inPROBE technology

Matt Sagan, of FiBioMed, shared a post on X:

“Innovative fiber optic–based approach of HER2 expression quantitative assessment using inPROBE technology.

inPROBE abstract at ASCO24.”

Additional information.
Source: Matt Sagan/X

 

 

Andrzej Kurylcio ASCO ASCO24 cancer Dariusz M. Stencel HER2 expression inPROBE inPROBE technology Magdalena Staniszewska Marcin Staniszewski Matt Sagan OncoDaily Oncology Przemysław Kopyto Wojciech Polkowski